Skip to main content
Psychopharmacology Bulletin logoLink to Psychopharmacology Bulletin
. 2020 Oct 15;50(4 Suppl 1):25–32. doi: 10.64719/pb.4379

Long-Term Outcomes of Post Dural Puncture Headache Treated With Epidural Blood Patch: A Pilot Study

Jamal Hasoon 1, Ivan Urits 1, Rana AL-Jumah 1, Mark Burroughs 1, Viet Cai 1, Omar Viswanath 1, Musa Aner 1, Paragi H Rana 1, Thomas Simopoulos 1, Alan D Kaye 1, Jatinder Gill 1
PMCID: PMC7901131  PMID: 33633415

Abstract

Background

Post dural puncture headache (PDPH) is a known complication which may occur in the setting of patients undergoing lumbar punctures (LP) for diagnostic or therapeutic purposes. The gold standard for treating a PDPH is an epidural blood patch (EBP). There have been few publications evaluating the long-term outcomes of PDPH treated with EBP. The aim of this pilot study was to examine the incidence of chronic headaches in dural puncture patients who received EBP versus those who did not.

Methods

A retrospective case control study was performed at a single large center institution. Forty-nine patients who had intentional dural puncture were identified on chart review and completed a survey questionnaire via phone interview: twenty-six of these patients required a subsequent EBP, while twenty-three did not. The primary outcomes were the development and prevalence of chronic headaches after the procedures. There was no statistically significant difference in the prevalence of current headaches between the EBP group and Non-EBP group (54% vs. 52% p = 0.91). There were no significant differences in the rates of severity and descriptive qualities of headache between the EBP and non-EBP groups. There was higher incidence of tinnitus in the PDPH patients.

Summary

This pilot study demonstrates that patients who received an EBP for treatment of a PDPH following LP are no more likely to experience chronic headaches compared to patients who do not receive an EBP. However, both the EBP group and Non-EBP group had high incidence of chronic headaches which may be related to dural puncture or a baseline trait of this cohort given the recall bias. There is a suggestion that tinnitus could be a long-term residual symptom of PDPH treated with EBP.

Keywords: post dural puncture headache, dural puncture, epidural blood patch, chronic headache, tinnitus

Introduction

Post dural puncture headache (PDPH) is defined as a positional headache that develops within 7 days after a dural puncture and is the most common complication associated with lumbar puncture (LP). Patients are at risk for increased morbidity due to the potential development of disabling symptoms which interfere with activities of daily living.1 The loss of intracranial cerebrospinal fluid (CSF) can be continuous through a dural tear and lead to a decrease in intracranial pressure with a compensatory cerebral vasodilation response. These changes can further cause mechanical traction on neurological structures when the patient is in the upright position leading to symptoms of orthostatic headache and pain.2–5

The development of PDPH following LP is dependent on needle shape and size, as well as patient risk factors including younger age, lower BMI, dehydration, history of previous PDPH or chronic headache.6–7 Patients may undergo a trial of conservative medical management that includes over the counter analgesics, caffeine and hydration. When conservative measures fail patients are commonly offered an epidural blood patch (EBP), which is considered the gold standard of treatment for debilitating PDPH symptoms.8–10 EBP involves injecting blood into the epidural space near the dural puncture site causing a clot formation to patch the dural defect. This mechanism ultimately leads to an increase in the intracranial CSF pressure relieving many of the symptoms associated with PDPH.11,12 Serious complications from untreated PDPH have been reported as chronic headaches, tinnitus and rare cases of subdural hematomas.13–17 Whereas, EBP is an established treatment for PDPH, this study was undertaken to determine the long-term outcomes of PDPH patients treated with EBP by comparing these to patients receiving dural puncture who did not receive EBP.

Methods

This pilot study was approved by the hospital institutional review board (Committee on Clinical Investigations). Once approved the study began with obtaining hospital ICD-9-CM procedure codes to identify patients who underwent lumbar punctures and then a subsequent epidural blood patch at Beth Israel Deaconess Medical Center (BIDMC) during the period extending from January 1, 2003 to December 31, 2013. A matched control group of patients who underwent lumbar punctures without subsequent epidural blood patch was then selected. Thus, one group underwent LP followed by subsequent EBP (EBP group), while the matched control group underwent LP without subsequent EBP (Non-EBP group). The groups were matched for variables of patient age at the time of the intervention, date that intervention occurred, and the index procedure. The data for back pain was also collected and will be presented separately. Similarly, the data for obstetric patients receiving PDPH with matched controls was also collected and presented separately.

The patients who were considered eligible for this study were contacted via telephone and requested to participate in the survey. The telephone interview was focused on patient specific symptoms regarding previous and current headaches they may have experienced. The primary outcome of the telephone survey was the presence of a current headache. The secondary outcomes included headache frequency, quality, intensity, as well as, tinnitus, debilitating effects on activities of daily living, pain analgesic medication usage, and interventional treatments.

Statistical Analysis

Descriptive statistics of the data were performed. Continuous data is represented as a mean (± SD). Variables not normally distributed as well as categorical data are presented using proportions. Chi square tests were used to evaluate differences in age, sex, race, ethnicity, and outcomes between patients using alpha ≤ 0.05. All statistical analysis was performed using SAS v9.4 (SAS Institute, Cary NC).

Results

The telephone questionnaire survey pertaining to headache characteristics was completed by a total of 49 patients. There were a total of 26 patients in the EBP group who underwent LP requiring a subsequent EBP for treatment of PDPH. The Non-EBP group consisted of 23 patients who underwent LP without a subsequent EBP.

There were no observed statistically significant differences between the groups of patients based off sex, race, mean age at the time of intervention, number of years since the lumbar puncture at the time the phone survey was conducted, and prevalence of self-reported pre-existing headache. Mean follow up period at the time of interview was 10.3 years in the EBP group and 11 years in the non-EBP group (Table 1).

Table 1. Demographic Summary of All Patients Who Underwent a Confirmed Dural Puncture via Diagnostic Lumbar Puncture, All N (%) Unless Otherwise Noted.

EBP (N = 26) Non-EBP (N = 23) P VALUE
Sex (Female) 20 (77) 17 (74) 0.8
Race (Caucasian) 16 (62) 17 (74) 0.4
Mean age at spinal procedure (SD) 31.8 (10.2) 31.3 (10.2) 0.9
Mean years since spinal procedure (SD) 10.3 (1.7) 11.0 (1.7) 0.13
Preexisting headache 10 (38) 7 (30) 0.77
Preexisting tinnitus 3 (12) 0 (0) 0.24*

Note: *Fisher’s Exact.

For the primary outcome, summarized in Table 2, there was no statistically significant difference in the prevalence of current headaches between the EBP group and Non-EBP group (54% vs. 52% p = 0.91). Both the EBP group and Non-EBP group demonstrated an increase in the prevalence of headache symptoms at follow up.

Table 2. Prevalence of Headache and Tinnitus in Patients Who Underwent a Confirmed Dural Puncture via Diagnostic Lumbar Puncture, All N (%), [95% CI].

EBP (N = 26) Non-EBP (N = 23) P VALUE
Headache 14 (54) 12 (52) 0.91
Tinnitus 7 (27) 1 (4) 0.052*

Note: *Fisher’s Exact.

Regarding the secondary outcomes, the EBP and Non-EBP groups showed no statistically significant differences in the headache pain severity reported by the patients on VAS, headache occurrence frequency, or various symptoms of headache dependent on positional movements (Table 3). There were also no statistically significant differences between the two groups in regards to proportion of patients requiring treatments. This study did demonstrate an increase in the prevalence of new onset tinnitus in the EBP group compared to the Non-EBP group (27% vs. 4% p = 0.052).

Table 3. Prevalence of Pain Severity Markers in Patients Reporting Significant Headaches (%) Unless Otherwise Noted.

EBP (N = 14) Non-EBP (N = 12) P Value
Frequency of HA
 0–7/mo 8 (57) 9 (75) 0.3
 > 7/month  6 (43)  3 (25) 0.4
Positional HA 6 (43) 4 (33) 0.6
HA > 5 in severity 10 (71) 11 (92) 0.19
Therapies attempted treatment of HA
 Prescription non-opiate 7 (50)  2 (17) 0.1
 Opiate 5 (36) 3 (25) 0.6
 OTC 10 (71) 10 (83) 0.5
 Pericranial nerve block with local anesthetic/Botox 3 (21) 1 (8) 0.4

Note: *Fisher’s Exact Test.

Discussion

PDPH resulting from dural puncture after LP may produce debilitating symptoms that can interfere with daily life. Patients who receive conservative treatment with hydration, caffeine, and over the counter analgesics usually have resolution of symptoms within one week from the onset of symptoms if conservative treatment is successful.18 Greater than 90% of patients who do not seek treatment for PDPH have total resolution of symptoms within 7–10 days. Although the majority of patients eventually have spontaneous resolution of PDPH, patients with debilitating symptoms may achieve definitive treatment with an EBP.19–22 However, there have also been reports of patients experiencing persistent headaches and auditory symptoms including tinnitus after the onset of PDPH.13–17,23

This pilot study wanted to further explore the long-term outcomes of PDPH treated with EBP. Our findings suggest that PDPH sufferers treated with EBP have the same incidence of headaches as patients with dural puncture who either did not develop PDPH or had PDPH but did not receive EBP; both group had similar rates of headaches (54% vs. 52% p = 0.91) (Table 2). There were no statistically significant differences in the headache pain severity on the VAS, headache occurrence frequency, or various symptoms of headache dependent on positional movements. These findings are reassuring that EBP is a safe and definitive treatment for PDPH. Given the small sample size, more definitive conclusion cannot be made. Nevertheless, it stands to reason that after the CSF leak stops, the component of headache related to this must as well. However, there was a high incidence of headaches in both groups which does raise the concern as to whether dural puncture itself can lead to chronic headaches, possibly related to sensitization. Whereas this is possible, more likely this is a function of recall bias as headache is a common problem in the general population and often an indication for dural puncture.

The results of this study were compared to various others reports that explored similar relationships between dural puncture, PDPH, EBP and subsequent chronic headaches. A case control study by Webb et al. reported chronic headache symptoms during an 18 month follow up in 25 subjects (20%) who had PDPH treated by EBP, compared to 40 controls (5%) that had no dural puncture or EBP.16 Our population differed from this study in that both our EBP and Non-EBP groups experienced dural puncture. Additionally, both of our groups experienced increases in prevalence of chronic headaches suggesting that dural puncture may be a risk factor for the development of chronic headaches.

Another study by Ranganathan et al. evaluated the development of headaches and other neurological disturbances in parturients who underwent labor epidurals with and without PDPH. This study evaluated 162 parturients who experienced a PDPH compared to 46 matched controls that did not develop PDPH and found significantly higher rates of headache symptoms in patients who developed PDPH (35% vs. 2%).15 A limitation of this study is a short six week follow up period used, though it does again suggest that patients who develop dural punctures or PDPH are at risk for developing chronic headaches.

An observational prospective study by Martinez et al. compared rates of headache and tinnitus after dural puncture in patients who underwent EBP along with those who did not receive subsequent EBP. This study found no statistically significant differences between patients who received EBP compared to those who did not receive subsequent EBP as both groups demonstrated similar rates of headache (6.1% vs 5.1%, p = 0.7), and tinnitus (3.1% vs 2.9%, p = 0.6) at 3 months.17 A limitation of this study was the follow up period of three months precludes conclusions regarding the long-term development of chronic headaches. The higher incidence of headaches in our study likely represents different cohort of patients.

In our study, patients in the EBP group had an increase in tinnitus symptoms when compared to the Non-EBP group (percentage difference 23% p = 0.052). Tinnitus is a common symptom of PDPH. The finding of increased tinnitus seen in PDPH group could be by chance given the small sample size or could also represent the fact that PDPH is more resistant to treatment by EBP compared to headaches. This finding may also suggest that tinnitus could be a long-term residual symptom of PDPH treated with EBP.

There are limitations with this pilot study given the limited patient population and retrospective design. The small sample size used for this pilot study prohibits definitive conclusions regarding long term outcomes of PDPH treated with EBP. The retrospective design of this study creates the risk of recall and attributional bias given the long follow up period between the described procedures and our survey for data collection. The increased incidence of headaches is more likely baseline rather than related to dural puncture especially since headaches are a very common clinical problem with roughly 46% of patients reporting headaches globally in the general population.24

Conclusion

The findings in this pilot study demonstrate that patients who experience PDPH after LP treated with EBP are no more likely to suffer from chronic headaches compared to patients who undergo LP and do not develop PDPH or develop PDPH but do not receive EBP. This study also demonstrates high incidence of headaches in lumbar puncture patients which may or may not be attributable to dural puncture given the recall bias. There is a suggestion that tinnitus may be a long-term residual symptom of PDPH treated with EBP.

Acknowledgments

Ariel Mueller, MA. Center for Anesthesia Research Excellence (CARE), Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center. Assisted with querying database for patients identified by inclusion/exclusion criteria and appropriate procedural codes.

Footnotes

Compliance with Ethics Guidelines

Conflict of Interest

The authors declare no conflicts of interest relevant to this manuscript.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Funding Statement

Support was provided solely from institutional and/or departmental sources at Beth Israel Deaconess Medical Center.

Conflicts of Interest

The authors declare no competing interests. The authors declare no financial conflicts of interest.

References

  • 1.Tohmo H, Vuorinen E, Muuronen A. Prolonged impairment in activities of daily living due to post-dural puncture headache after diagnostic lumbar puncture. Anaesthesia. 1998 Mar;53(3):299–302. doi: 10.1046/j.1365-2044.1998.00326.x. [DOI] [PubMed] [Google Scholar]
  • 2.Mokri B. The Monro-Kellie hypothesis: applications in CSF volume depletion. Neurology. 2001 Jun 26;56(12):1746–1748. doi: 10.1212/wnl.56.12.1746. [DOI] [PubMed] [Google Scholar]
  • 3.Gormley JB. Treatment of post-spinal headache. Anesthesiology. 1960;21:565–566. [Google Scholar]
  • 4.Turnbull DK, Shepherd DB. Post-dural puncture headache: pathogenesis, prevention and treatment. Br J Anaesth. 2003 Nov;91(5):718–729. doi: 10.1093/bja/aeg231. [DOI] [PubMed] [Google Scholar]
  • 5.Bezov D, Lipton RB, Ashina S. Post-dural puncture headache: Part I diagnosis, epidemiology, etiology, and pathophysiology. Headache. 2010;50(7):1144–1152. doi: 10.1111/j.1526-4610.2010.01699.x. **(good review of post-dural puncture headache) [DOI] [PubMed] [Google Scholar]
  • 6.Bezov D, Ashina S, Lipton R. Post-dural puncture headache: Part II – Prevention, management, and prognosis. Headache. 2010;50(9):1482–1498. doi: 10.1111/j.1526-4610.2010.01758.x. **(good review of post-dural puncture headache) [DOI] [PubMed] [Google Scholar]
  • 7.Waise S, Gannon D. Reducing the incidence of post-dural puncture headache. Clin Med. 2013;13(1):32–34. doi: 10.7861/clinmedicine.13-1-32. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Safa-tisseront V, Thormann F, Malassiné P, Henry M, Riou B, Coriat P, Seebacher J. Effectiveness of Epidural Blood Patch in the Management of Post – Dural Puncture Headache. 2015;2:334–339. doi: 10.1097/00000542-200108000-00012. [DOI] [PubMed] [Google Scholar]
  • 9.Taivainen T, Pitkanen M, Tuominen M, Rosenberg PH. Efficacy of Epidural Blood Patch for Postdural Puncture Headache. Acta AnaesthesiolScand. 1993;37:702–705. doi: 10.1111/j.1399-6576.1993.tb03793.x. [DOI] [PubMed] [Google Scholar]
  • 10.Van Kooten F, Oedit R, Bakker SLM, Dippel DWJ. Epidural blood patch in post dural puncture headache: A randomised, observer-blind, controlled clinical trial. J Neurol Neurosurg Psychiatry. 2008;79(5):553–558. doi: 10.1136/jnnp.2007.122879. ***(excellent study on the role of epidural blood patch in the treatment of post-dural puncture headache) [DOI] [PubMed] [Google Scholar]
  • 11.Wilton NC, Globerson JH, de Rosayro AM. Epidural blood patch for postdural puncture headache: it’s never too late. Anesth Analg. 1986;65(8):895–896. [PubMed] [Google Scholar]
  • 12.Thew M, Paech MJ. Management of postdural puncture headache in the obstetric patient. Curr Opin Anaesthesiol. 2008 Jun;21(3):288–292. doi: 10.1097/ACO.0b013e3282f8e21a. [DOI] [PubMed] [Google Scholar]
  • 13.Zeidan A, Farhat O, Maaliki H, Baraka A. Does postdural puncture headache left untreated lead to subdural hematoma? Case report and review of the literature. Int J Obstet Anesth. 2006 Jan;15(1):50–58. doi: 10.1016/j.ijoa.2005.07.001. [DOI] [PubMed] [Google Scholar]
  • 14.Erol A, Topal A, Arbag H, Kilicaslan A, Reisli R, Otelcioglu S. Auditory function after spinal anaesthesia: the effect of differently designed spinal needles. Eur J Anaesthesiol. 2009 May;26(5):416–420. doi: 10.1097/EJA.0b013e32831c89d4. [DOI] [PubMed] [Google Scholar]
  • 15.Ranganathan P, Golfeiz C, Phelps AL, Singh S, Shnol H, Paul N, Attaallah AF, Vallejo MC. Chronic headache and backache are long-term sequelae of unintentional dural puncture in the obstetric population. J Clin Anesth. 2015;27(3):201–206. doi: 10.1016/j.jclinane.2014.07.008. [DOI] [PubMed] [Google Scholar]
  • 16.Webb C, Weyker P, Zhang L, Stanley S, Coyle T, Tang T, Smiley R, Flood P. Unintentional Dural Puncture with a Tuohy Needle Increases Risk of Chronic Headache. Anesth Analg. 2012 Jul;115(1):124–132. doi: 10.1213/ANE.0b013e3182501c06. [DOI] [PubMed] [Google Scholar]
  • 17.Martínez B, Cuenca E, Babarro A, Yanci E, AS Dávila E, Díaz E, Sebastián J, Rodríguez F. Postdural Puncture Headache and Epidural Blood Patch in a Large Obstetric Anaesthesia Population. Asian J Anesthesiol. 2018;56(1):23–32. doi: 10.6859/aja.201803_56(1).0003. [DOI] [PubMed] [Google Scholar]
  • 18.Lybecker H, Djernes M, Schmidt JF. Postdural pucnture headache (PDPH): Onset, duration, severity, and associated symptoms. An analsyeis of 75 consecutive patients with PDPH. Acta AnaesthesiolScand. 1995;39(1 995):605–612. doi: 10.1111/j.1399-6576.1995.tb04135.x. [DOI] [PubMed] [Google Scholar]
  • 19.Boonmak P, Boonmak S. Chichester, UK: John Wiley & Sons, Ltd; 2010. Epidural blood patching for preventing and treating post-dural puncture headache. In: Cochrane Database of Systematic Reviews; p. CD001791. [DOI] [PubMed] [Google Scholar]
  • 20.Safa-Tisseront V, Thormann F, Malassiné P, Henry M, Riou B, Coriat P, Seebacher J. Effectiveness of epidural blood patch in the management of post-dural puncture headache. Anesthesiology. 2001 Aug;95(2):334–339. doi: 10.1097/00000542-200108000-00012. [DOI] [PubMed] [Google Scholar]
  • 21.Taivainen T, Pitkänen M, Tuominen M, Rosenberg PH. Efficacy of epidural blood patch for postdural puncture headache. Acta Anaesthesiol Scand. 1993 Oct;37(7):702–715. doi: 10.1111/j.1399-6576.1993.tb03793.x. [DOI] [PubMed] [Google Scholar]
  • 22.van Kooten F, Oedit R, Bakker SLM, Dippel DWJ. Epidural blood patch in post dural puncture headache: a randomised, observer-blind, controlled clinical trial. J Neurol Neurosurg Psychiatry. 2008 May 1;79(5):553–558. doi: 10.1136/jnnp.2007.122879. [DOI] [PubMed] [Google Scholar]
  • 23.Abouleish E, Vega S, Blendinger I, Tio TO. Long-term follow-up of epidural blood patch. Anesth Analg. 1975;54(4):459–463. doi: 10.1213/00000539-197554040-00012. [DOI] [PubMed] [Google Scholar]
  • 24.Stovner LJ, Hagen K, Jensen R, Katsarava Z, Lipton RB, Scher AI, Steiner TJ, Zwart JA. The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia. 2007 Mar;27(3):193–210. doi: 10.1111/j.1468-2982.2007.01288.x. [DOI] [PubMed] [Google Scholar]

Articles from Psychopharmacology Bulletin are provided here courtesy of MedWorks Media Inc.

RESOURCES